DJ Vertex Pharmaceuticals Inc. Stock Rises Friday, Still Underperforms Market
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Vertex Pharmaceuticals Inc. $(VRTX)$ inched 0.13% higher to $450.97 Friday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index rising 0.35% to 5,969.34 and the Dow Jones Industrial Average rising 0.97% to 44,296.51.
Vertex Pharmaceuticals Inc. closed $68.91 below its 52-week high ($519.88), which the company reached on November 8th.
The stock demonstrated a mixed performance when compared to some of its competitors Friday, as AbbVie Inc. $(ABBV)$ rose 3.04% to $176.95, Krystal Biotech Inc. (KRYS) rose 4.45% to $190.40, and Arcturus Therapeutics Holdings Inc. $(ARCT)$ fell 0.94% to $16.91.
Data source: Dow Jones Market Data, FactSet. Data compiled November 22, 2024.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
November 22, 2024 16:42 ET (21:42 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.
Comments